590 likes | 1.01k Views
Sudden Death in Adult Congenital Heart Disease (GUCH Patients). Berardo Sarubbi U.O.C. di Cardiologia U.O. Cardiopatie Congenite dell’Adulto Seconda Università degli Studi di Napoli - A.O. Monaldi. Adults Congenital Heart Disease. Italy: Incidence 8 per thousand
E N D
Sudden Death in Adult Congenital Heart Disease (GUCH Patients) Berardo Sarubbi U.O.C. diCardiologia U.O. CardiopatieCongenitedell’Adulto SecondaUniversitàdegliStudidi Napoli - A.O. Monaldi
Adults Congenital Heart Disease • Italy: • Incidence 8 per thousand • In the last 20 years 90.000 pts with CHD 100.000 pts with CHD aged >18 yrs 70.000 pts with CHD aged <18 yrs
“Pediatriccongenitalcardiacbecomes a postoperativeadult: the changingpopulationofcongenitalheartdisease”Perloff JK. Circulation1973; 47:606-619 …itissimple a matteroftimebefore a populationofadultwithcongenitalheartdiseasewould emerge.
Percento Congenital Heart Disease in the General Population Changing Prevalence and Age Distribution. J. Marelli et al. Circulation. 2007;115:163-172.
Changes of GUCH population over the time ASD/VSD TOF Mustard/Senning Fontan HLHS Truncus 2011 20 30 40 50 60 ASD/VSD TOF Mustard/Senning Fontan 2021 HLHS Truncus 20 30 40 50 60
CLINICAL EVENTSAFTER SURGICAL CORRECTION:ventriculardysfunction, arrhythmias, re-intervention
Causes of Death in GUCH Oechsling et al Am J Cardiol 2000
Event GUCH Sudden Death Other 7 (7.4%) Haemorrhagic 17 (18.1%) Unknown 37 (39.4%) Arrhythmic 33 (35.1%) Sudden death is the most frequent cause of late mortality in adults with CHD Sarubbi B., Somerville J.:Sudden death in grown-up congenital heart (GUCH) patients: a 26-year population-based study. JACC 1999
Late Death in Repaired Tetralogy 793 adult pts (1985-95) 33 pts died (4.2% mortality) Gatzoulis et al Lancet 2000
CAUSES OF ADMISSION FOR GUCH Report of the British Cardiac Society - Heart 2002;88:i1-i14
GUCH Admission - Year 2010 Percentage of Fallot admitted for arrhythmias A.O. Monaldi Napoli
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
Arrhythmias in GUCH RISK STRATIFICATION Clinical History • Previous Surgical Intervention • Previous Palliative Intervention • Age at operation • Type of Surgical Approach • Follow-up duration
TOF: Arrhythmic Risck SD Incidencebetween 0.5 to 5.5% “Scarrelated” VT • Ventriculotomy • Interventricular Patch • RVOT Patch
Presence of symptoms of Arrhythmia or Heart Failure • History of documented AFL/AF The best predictors of SCD
Arrhythmias, Heart Failure and SD in GUCH SVT Heart Failure Sistolic-diastolic dysfunction Increased HR Neurohormonal Activation Reduction of the ventricle filling time Reduction in C.O.
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
GatzoulisM.A., et al: Mechano-electricalInteraction in TetralogyofFallot. Circulation 1995
Sarubbi B., Somerville J.:Sudden death in grown-up congenital heart (GUCH) patients: a 26-year population-based study. Journal American College of Cardiology 1999. O=Repaired FallotO= Unrepaired Fallot SD not related to width of QRS
Measurement of QRS is difficult • Can be operator dependent • Can be influenced by the presence of conduction abnormalities which reduce its accuracy and reproducibility.
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
SignalAverage ECG Time domain High accuracy of Signal Average ECG to predict severe VA Pts operated on for TOF : Frequency domain Y Z X *p<0.001 vs pts with minor and severe arrhythmias. #< 0.01vs pts with severe arrhythmias
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
EPS inducible sustained VT VT or SCD Khairy et al, Circulation 2004
7% of pts with neg. VSTIM studies died during follow-up • 37% of pts with documented sustained VT/VF had no inducible ventricular arrhythmia with VSTIM Alexander M.E, Walsh E.P.: J.Cardiovasc. Electr.
Very low positive predictive value (20%) of VSTIM to predict SCD • Proarrhythmia of antiarrhythmic drugs • Management of pts with spontaneous VT and non inducible arrhythmias Alexander M.E, Walsh E.P.: J.Cardiovasc. Electr.
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
ATRIAL FLUTTER and RV FUNCTION after MUSTARD 1 normal; 2 milddepression; 3 moderate depression; 4 severe depression. Gelatt M J et al. JACC, Jen1997: 29 (1); 194-201
Normal-Mild LV systolic dysf. The combination of QRS ≥180ms and significant LV syst. dysfunction has a positive predictive value for SCD of 66% and negative predictive value of 93% Mod-Severe LV systolic dysf.
Right and Left ventricular interaction At rest (MRI) Davlouros et al JACC 2002
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
MYOCARDAL FIBROSIS AND LIFE THREATENING VENTRICULAR ARRHYTHMIAS
3D Late Gad CMR 3D CMR EP Merge VT ablated at site RVOT scar RVOT scar
AdultCongenitalHeartDiseasePts Riskstratificationfor S.D. • Clinical History • ECG Parameters • SAECG/LP • EPS • RV/LV Emodinamics, Volume, Function • Tissutal characterization • Autonomic Nervous System
ToF patients with VT have significant impairment of sympatho-vagal balance, characterized by a reduction of vagal drive
strategies to prevent SD in GUCH
Issues for the use of AICD in ACHD • Indications • Inappropriate shocks and lead failure • Unique anatomical situations in CHD • Technical difficulties
CHD patients are not mentioned as a different group and it is assumed that general guidelines are applicable to these patients as there are not yet clear indications for AID therapy in this group
No data in the literature comparing medical therapy with AID implantation in either paediatric or adult CHD population • Attempt to ablate the VT focus either in the EP lab or in the operating room in ACHD before considering AID implantation • Long term efficacy and safety of this approach in ACHD in unknown International J. of Cardiology 2008
20 pts aged 16±6yrs • 11 CHD • 6 Epicardial; 14 transvenous • Therapy-rate 2.8 per patient-years of F-U • 53% appropriate; 47% inappropriate • 1.5 appropriate per patient-year of FU • 1.3 inappropriate per patient-year of FU PACE 2004; 27:924-932